HMGB1, a pro-inflammatory cytokine of clinical interest: Introduction

Journal of Internal Medicine

Volumn 255, Issue 3, 2004, Pages 318-319

  Andersson, U G ^a   Tracey, K J ^b  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^b North Shore LIJ Research Institute ^*  (United States)

Author keywords

Cytokine; HMGB1; Inflammation; Necrosis; RAGE ligand; Sepsis

Indexed keywords

ANTIINFLAMMATORY AGENT; CYTOKINE; CYTOKINE ANTIBODY; HIGH MOBILITY GROUP B1 PROTEIN; HIGH MOBILITY GROUP B1 PROTEIN ANTAGONIST; HIGH MOBILITY GROUP B1 PROTEIN ANTIBODY; UNCLASSIFIED DRUG;

APOPTOSIS; ARTHRITIS; CONFERENCE PAPER; CYTOKINE RELEASE; DISEASE SEVERITY; HUMAN; INFLAMMATORY DISEASE; NECROSIS; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN CONTENT; PROTEIN FUNCTION; SEPSIS; TREATMENT OUTCOME;

HMGB1 PROTEIN; HUMANS; INFLAMMATION;

EID: 1542375215     PISSN: 09546820     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2796.2003.01304.x     Document Type: Conference Paper

References (16)

1. Feldmann M, Brennan FM, Foxwell BM, Maini RN. The role of TNF alpha and IL-1 in rheumatoid arthritis. Curr Dir Autoimmun 2001; 3: 188-99.
2. D'Haens G. Anti-TNF therapy for Crohn's disease. Curr Pharm Des 2003; 9: 289-94.
3. Wang H, Bloom O, Zhang M et al. HMG-1 as a late mediator of endotoxin lethality in mice. Science 1999; 285: 248-51.
4. Bustin M. Regulation of DNA-dependent activities by the functional motifs of the high-mobility-group chromosomal proteins. Mol Cell Biol 1999; 19: 5237-46.
5. Merenmies J, Pihlaskari R, Laitinen J, Wartiovaara J, Rauvala H. 30-kDa heparin-binding protein of brain (amphoterin) involved In neurite outgrowth. Amino acid sequence and localization in the filopodia of the advancing plasma membrane. J Biol Chem 1991; 266: 16722-29.
6. Huttunen HJ, Rauvala H. Amphoterin (HMGB1) as an extracellular regulator of cell motility: from development to disease. J Intern Med 2004; 255: 343-59.
7. Wang H, Yang H, Tracey KJ. Extracellular role of HMGB1 in inflammation and sepsis. J Intern Med 2004; 255: 312-23.
8. Kokkola R, Sundberg E, Ulfgren AK et al. High mobility group box chromosomal protein 1: a novel proinflammatory mediator in synovitis. Arthritis Rheum 2002; 46: 2598-603.
9. Taniguchi N, Kawahara K, Yone K et al. High mobility group box chromosomal protein 1 plays a role in the pathogenesis of rheumatoid arthritis as a novel cytokine. Arthritis Rheum 2003; 48: 971-81.
10. Yang H, Ochani M, Li J et al. Reversing established sepsis with antagonists of endogenous HMGB1. Proc Natl Acad Sci (USA) 2004; 101: 296-301.
11. Andersson U, Erlandsson-Harris H. HMGB1 is a potent trigger of arthritis. J Intern Med 2004; 255: 336-42.
12. Scaffidi P, Misteli T, Bianchi ME. Release of chromatin protein HMGB1 by necrotic cells triggers inflammation. Nature 2002; 418: 191-5.
13. Müller S, Ronfani L, Bianchi ME. Regulated expression and subcellular localization of HMGB1, a chromatin protein with a cytokine function. J Intern Med 2004; 255: 324-35.
14. Ombrellino M, Wang H, Ajemian MS et al. Increased serum concentrations of high-mobility-group protein 1 in haemorrhagic shock. Lancet 1999; 354: 1446-7.
15. Huttunen HJ, Fages C, Kuja-Panula J, Ridley AJ, Rauvala H. Receptor for advanced glycation end products-binding COOH-terminal motif of amphoterin inhibits invasive migration and metastasis. Cancer Res 2002; 62: 4805-11.
16. Taguchi A, Blood DC, del Toro G et al. Blockade of RAGE-amphoterin signalling suppresses tumour growth and metastasis. Nature 2000; 405: 354-60.